quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:51:25·21d
SECFiling
Pharvaris N.V. logo

SEC Form 20-F filed by Pharvaris N.V.

PHVS· Pharvaris N.V.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • PHVS
    Pharvaris N.V.
    Health Care

Recent analyst ratings

  • Apr 9UpdateWolfe Research$42.00
  • Mar 9UpdateRBC Capital Mkts$52.00
  • Oct 15UpdateH.C. Wainwright$60.00
  • Oct 9UpdateBofA Securities$27.00
  • Jun 11UpdateGuggenheim$32.00
  • Apr 29UpdateCantor Fitzgerald$28.00

Related

  • SEC1d
    SEC Form 144 filed by Pharvaris N.V.
  • SEC1d
    SEC Form 144 filed by Pharvaris N.V.
  • INSIDER3d
    SEC Form 4 filed by Lu Peng
  • INSIDER3d
    SEC Form 4 filed by Modig Berndt
  • PR3d
    Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
  • SEC7d
    SEC Form 144 filed by Pharvaris N.V.
  • INSIDER9d
    SEC Form 4 filed by Nijdam Anna
  • INSIDER13d
    SEC Form 4 filed by Modig Berndt
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022